Skip to content

CogMax: A Healthy Brain Ageing cognitive training and psychoeducation program for older adults.

CogMax: A Healthy Brain Ageing cognitive training and psychoeducation program for older adults – comparing facilitated vs independent delivery.

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001542280
Enrollment
38
Registered
2018-09-14
Start date
2018-12-05
Completion date
2021-06-03
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This feasibility pilot study will compare two methods of delivery, facilitated by a Neuropsychologist or completed independently, for an evidence-based, structured Healthy Brain Ageing (HBA) cognitive training (CT) and psychoeducation program, designed to improve cognitive and psychosocial functioning in people with Subjective Cognitive Impairment (SCI), Mild Cognitive Impairment (MCI) or Parkinson’s Disease (PD). While the program has been shown to be successful in over 350 participants to-date, it has previously only been offered in-person in group-based sessions, which has limited translational capacity. We now seek to evaluate other delivery methods with a view to more readily providing this program to individuals in the community in the future, pending trial outcomes.

Interventions

CogMax is a ten-week psychoeducation and cognitive training program targeting common cognitive concerns experienced by many older adults, as well as modifiable risk factors for dementia. Based on previously published work reporting outcomes from a group-based multifaceted Healthy Brain Ageing intervention program (for example, see Diamond et al., 2015, J Alz Dis; Naismith et al., 2011, Am J Geriatr Psychiatry; Mowszowski et al., 2014, J Alz Dis); we now seek to evaluate an adapted version of the

CogMax is a ten-week psychoeducation and cognitive training program targeting common cognitive concerns experienced by many older adults, as well as modifiable risk factors for dementia. Based on previously published work reporting outcomes from a group-based multifaceted Healthy Brain Ageing intervention program (for example, see Diamond et al., 2015, J Alz Dis; Naismith et al., 2011, Am J Geriatr Psychiatry; Mowszowski et al., 2014, J Alz Dis); we now seek to evaluate an adapted version of the program for completion on a one-to-one basis or independently, which will enable a broader group of older people to access the intervention. The program has been adapted to a structured workbook format, with topics arranged into five core ‘cognitive’ modules and five health/psychosocial/lifestyle modules addressing risk factors for dementia. Each module will provide participants with education and practical instruction on a variety of strategies targeting cognition, mood disturbance, and medical or lifestyle factors known to affect cognition and psychosocial wellbeing. All participants will complete a total of 10-weekly modules over the course of the intervention period. Ideally, this period will therefore last 10-weeks; however, if needed, the 10 modules may be completed over a maximum of 12-weeks, to allow for some flexibility in the event of pre-existing travel plans or unanticipated changes in availability (e.g. due to illness). The modules include: 1. Introduction to the Brain and Cognitive Changes in Ageing, including Goal Setting 2. Introduction to Learning and Memory 3. External Memory Strategies 4. Internal Memory Strategies 5. Executive Functions 6. Vascular Risk Factors 7. Diet and Exercise 8. Sleep Habits and Sleep Quality 9. Depression and Anxiety 10. Behavioural and Psychological Strategies for Wellbeing Therapist-facilitated condition: Participants allocated to the facilitated condition will attend the Brain and Mind Centre (BMC) in Sydney, Australia, once a week at a mutually agreed time to meet with a trained neuropsychologist or closely supervised postgraduate neuropsychology student, for one hour. During these one-on-one sessions, participants will complete one module from the workbook, starting with Module 1 (Introduction to the Brain and Cognitive Changes in Ageing). The neuropsychologist will work through the psychoeducation material and cognitive strategies with the participant, to actively facilitate and maximise optimal comprehension and applicability to their individual circumstances, using personalised examples. Additionally, the neuropsychologist will utilise clinical techniques such as collaborative goal-setting and motivational interviewing to identify the most clinically relevant issues for each individual. With this information, the therapist may recommend that the participant complete the modules in a different order to that set out in the workbook, to ensure optimal engagement and the ability to address critical or significant issues as a matter of priority. Each session, the therapist will also review the homework tasks completed by the participant following the previous session, to aid in the participant’s self-evaluation of their progress and address any barriers to meeting their goals.

Sponsors

The University of Sydney
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• >= 50 years of age; • Subjective Memory Impairment (SCI), Mild Cognitive Impairment (MCI) or Parkinson’s Disease (PD) with cognitive complaints; • Mini Mental State Examination (MMSE) score >24 or Montreal Cognitive Assessment score >=26; • Willing and able to attend the BMC once a week at a mutually agreed time for therapy sessions, if randomly allocated to the facilitated condition; • Willing and able to remain in contact with the study team for the duration of the trial, including attending the BMC for baseline and follow-up assessments.

Exclusion criteria

• Intellectual or developmental disability • Previous head injury with loss of consciousness > 30 minutes • History of stroke or seizures • History of neurological illness (other than Parkinson’s disease) • History of psychiatric illness (other than affective disorder – e.g., schizophrenia, bipolar disorder, PTSD) • History of electroconvulsive therapy or deep brain stimulation • Current/past alcohol or substance dependence (other than nicotine) • Current medical condition which may affect cognition (e.g., cancer, chronic fatigue syndrome) • Concurrent use of other psychological or computerized CT therapy (internet or clinician-delivered)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026